Search Results
Nov 12, 2025, 08:00 ET Cypherpunk Technologies (formerly Leap Therapeutics) Reports Third Quarter 2025 Financial Results
potential markets for sirexatamab and FL-501; (vi) the benefits to be derived from any collaborations, license agreements, or other acquisition efforts; (vii) sources of revenues and anticipated revenues, including contributions from any collaborations or license agreements for the development and commercialization
More news about: Cypherpunk Technologies Inc.
Nov 12, 2025, 08:00 ET Cypherpunk Technologies (formerly Leap Therapeutics) Reports Third Quarter 2025 Financial Results
potential markets for sirexatamab and FL-501; (vi) the benefits to be derived from any collaborations, license agreements, or other acquisition efforts; (vii) sources of revenues and anticipated revenues, including contributions from any collaborations or license agreements for the development and commercialization
More news about: Cypherpunk Technologies Inc.
Nov 12, 2025, 07:44 ET Smart Sand, Inc. Announces Third Quarter 2025 Results
non-recurring cash charges related to restructuring, retention and other similar actions; (vi) earn-out, contingent consideration obligations; and (vii) non-cash charges and unusual or non-recurring charges. Adjusted EBITDA is used as a supplemental financial measure by management and by external users
More news about: Smart Sand, Inc.
Nov 11, 2025, 17:30 ET Adecoagro S.A.:Adjusted EBITDA reached $115.1 million in 3Q25. All-time crushing record and switch to ethanol maximization. Challenging global price scenario continues.
our potential purchase of Profertil), joint ventures, strategic alliances or divestitures, and to consolidate our position in different businesses; (vii) the efficiencies, cost savings and competitive advantages resulting from acquisitions; (viii) the implementation of our financing strategy, capital
More news about: Adecoagro S.A.
Nov 11, 2025, 16:05 ET Shoulder Innovations Reports Third Quarter 2025 Financial Results and Increases Full-Year Revenue Guidance
associated with litigation; (vi) our dependence upon the adoption of our implant systems by hospitals, ambulatory surgery centers, surgeons and patients; (vii) our ability to enhance our implant systems, expand our indications and develop and commercialize additional products in a timely manner; (viii) risks
More news about: Shoulder Innovations
Nov 10, 2025, 20:09 ET DOMA Perpetual Sends Letter Calling for the Board of Directors of Pacira BioSciences, Inc. to Immediately Explore a Sale of the Business
DOMA Perpetual Internal Calculationsvi Pacira BioSciences, Inc. Company Filings, DOMA Perpetual Internal Calculationsvii Pacira BioSciences, Inc. Proxy Materials, DOMA Perpetual Internal Calculationsviii Pacira BioSciences, Inc. Company Filingsix Bloomberg
More news about: DOMA Perpetual
Nov 10, 2025, 16:30 ET LivePerson Announces Third Quarter 2025 Financial Results
costs; (vi) non-GAAP sales and marketing expenses, or sales and marketing expenses excluding stock based compensation and leadership transition costs; (vii) non-GAAP general and administrative expenses, or general and administrative expenses excluding stock based compensation, other litigation, consulting
More news about: LivePerson
Nov 10, 2025, 16:15 ET Summit Midstream Corporation Reports Third Quarter 2025 Financial and Operating Results
volume commitments ("MVC") shortfall payments, (v) adjustments related to capital reimbursement activity, (vi) share-based and noncash compensation, (vii) impairments and (viii) other noncash expenses or losses, less other noncash income or gains.
More news about: Summit Midstream Corporation
Nov 10, 2025, 08:00 ET Johnson & Johnson lança plataforma VARIPULSE™ no Brasil e avança no tratamento da fibrilação atrial
vi , vii , viii
More news about: Johnson & Johnson MedTech
Nov 10, 2025, 07:00 ET Powerfleet Reports Q2 FY26 Financial Results with 7% Quarterly Sequential Increase in Total Revenue
risks and our ability to protect our information technology systems from breaches; (vi) our inability to adequately protect our intellectual property; (vii) competitive pressures from a broad range of local, regional, national and other providers of wireless solutions; (viii) our ability to effectively navigate
More news about: Powerfleet
Nov 10, 2025, 06:30 ET G Mining Ventures Completes First Drawdown on US$350 Million Revolving Credit Facility
attractive for mining investment; (v) Oko West will advance responsibly and on schedule; (vi) GMIN will achieve its stated objectives for Oko West; or (vii) TZ and Oko West will grow GMIN into the next intermediate producer, as future events could differ materially from what is currently anticipated by the
More news about: G Mining Ventures Corp
Nov 08, 2025, 17:45 ET New Data from REZOLVE-AD Study of Rezpegaldesleukin Presented in Late-Breaking Oral Abstract Presentation at ACAAI 2025 Annual Scientific Meeting
markets; (vi) a Fast Track designation does not increase the likelihood that rezpegaldesleukin will receive marketing approval in the United States; (vii) patents may not issue from our patent applications for our drug candidates, patents that have issued may not be enforceable, or additional intellectual
More news about: Nektar Therapeutics
Nov 07, 2025, 16:05 ET Lazydays Announces Plan to Delist from Nasdaq
return to the stockholders of the Company, based on their junior priority relative to the priority of the Company's secured and unsecured creditors; (vii) the Common Stock is highly speculative and poses substantial risks, and Company stockholders are currently expected to experience a complete loss of
More news about: Lazydays RV
Nov 06, 2025, 18:09 ET CapitalSpring Closes on Initial $505 Million of $1 Billion Target just Two Months After the Launch of its Seventh Flagship Investment Fund
sixth-largest restaurant franchisee nationwide with over $1 billion in annual system revenue. Building on this track record, Fund VII will continue to pursue opportunities across the foodservice, franchising, and multi-unit business ecosystem, leveraging CapitalSpring's 20-year foundation
More news about: Capital Spring
Nov 06, 2025, 16:17 ET FNF Reports Third Quarter 2025 Financial Results
not reasonably likely to recur within two years and/or there was not a similar item in the preceding two years; vii. Non-controlling interest on non-GAAP adjustments: the portion of the non-GAAP adjustments attributable to the equity interest of entities that FNF does
More news about: Fidelity National Financial, Inc.
Nov 06, 2025, 16:15 ET Nektar Therapeutics Reports Third Quarter 2025 Financial Results
markets; (vi) a Fast Track designation does not increase the likelihood that rezpegaldesleukin will receive marketing approval in the United States; (vii) patents may not issue from our patent applications for our drug candidates, patents that have issued may not be enforceable, or additional intellectual
More news about: Nektar Therapeutics
Nov 06, 2025, 16:15 ET F&G Annuities & Life Reports Third Quarter 2025 Results
(vii) Income taxes: the income tax impact related to the above-mentioned adjustments is measured using an effective tax rate, as appropriate by tax jurisdiction.
More news about: F&G Annuities & Life, Inc.
Nov 06, 2025, 16:11 ET Saul Centers, Inc. Reports Third Quarter 2025 Earnings
ability to consummate planned and additional financings on acceptable terms, (v) our development activities, (vi) our access to additional capital, (vii) our ability to successfully complete additional acquisitions, developments or redevelopments, or if they are consummated, whether such acquisitions,
More news about: Saul Centers, Inc.
Nov 06, 2025, 16:05 ET iRobot Reports Third-Quarter 2025 Financial Results
restructuring will harm its business, including current plans and operations; (vi) the ability of the Company to retain and hire skilled personnel; (vii) loss of any key employee; (viii) failure of the Company's primary contract manufacturer to meet the Company's requirements; (ix) legislative, regulatory
More news about: iRobot Corporation
Nov 06, 2025, 16:05 ET Ginkgo Bioworks Reports Third Quarter 2025 Financial Results
biosecurity industry, including due to advancements in technology, emerging competition and evolution in industry demands, standards and regulations, (vii) the outcome of any pending or potential legal proceedings against Ginkgo, (viii) our ability to realize the expected benefits from and the success of
More news about: Ginkgo Bioworks
Nov 06, 2025, 06:45 ET Nomad Foods Reports Third Quarter 2025 Financial Results
shareholder returns; (v) its bottom-line growth and cash generation; (vi) its portfolio's ability to remain well positioned for consumer trends; and (vii) Mr. Brisby's ability to improve the Company's results and growth. These statements are not guarantees of future performance and
More news about: Nomad Foods Limited
Nov 06, 2025, 06:45 ET Quarterhill Announces Q3 2025 Financial Results
(iv) other charges and other one-time items; (v) depreciation of right-of-use assets and property, plant and equipment; (vi) stock-based compensation; (vii) foreign exchange (gain) loss ; (viii) other (income) expense; and (ix) changes in fair value of derivative liability. Adjusted EBITDA is used by our
More news about: Quarterhill Inc.
Nov 06, 2025, 06:00 ET DuPont Reports Third Quarter 2025 Results; Announces Plans to Return Cash to Shareholders
and other disasters or weather-related events; (vi) the ability to offset increases in cost of inputs, including raw materials, energy and logistics; (vii) the risks and uncertainties associated with continuing or expanding trade disputes or restrictions and responsive actions, new or increased tariffs
More news about: DuPont
Nov 06, 2025, 02:50 ET The Annual Final Window for Retail Buyers! Full Category Coverage + Precise Matchmaking. FHC2025 Offers One-Stop Solution for 2026 Hot-Selling Product Sourcing! 【Free Ticket Registration Closing Soon】
expansion strategies, helping food and beverage practitioners capture new market growth opportunities. VII. Golden Apple Awards: Industry Quality Benchmark, Providing Sourcing Reference FHC Golden Apple Awards have
More news about: FHC Shanghai Global Food Trade Show
Nov 05, 2025, 20:33 ET SIERRACOL ENERGY ANNOUNCES EARLY TENDER RESULTS
(iii) terminate the Tender Offer, (iv) increase the Maximum Amount, (v) extend the Withdrawal Deadline, (vi) extend or amend the Expiration Time, or (vii) modify the Tender Offer Consideration, in each case (other than clause (v)) without extending the Withdrawal Deadline or otherwise reinstating withdrawal
More news about: SierraCol Energy Limited